Filing summary
Baird Medical Investment Holdings Limited furnished this Form 6-K in September 2026. The filing identifies Exhibit 99.1 as unaudited interim condensed consolidated financial statements as of December 31, 2025 and June 30, 2026, and for the six months ended June 30, 2025 and June 30, 2026. Exhibit 99.2 is management’s discussion and analysis.
Financial results and changes
The supplied filing text contains no financial statement details or MD&A figures. Revenue, profit, cash flow, margins, debt, liquidity, and changes versus the prior period cannot be determined from this text.
Outlook, risks, and unusual items
No guidance, outlook, management commentary, risks, contingencies, or unusual financial items are described in the supplied text.
Filing details
The report says its attached document is incorporated by reference into the specified registration statements. It is signed by Chairwoman and Chief Executive Officer Haimei Wu and dated September 30, 2026.
Important facts to verify
- Review Exhibits 99.1 and 99.2 for the actual interim results, comparative changes, liquidity and debt disclosures, and management’s outlook and risk discussion.
- Confirm the reporting-period figures and any material events disclosed in the exhibits; they are not included in the supplied text.